Akebia Therapeutics
AKBA
#9494
Rank
โ‚ฌ0.11 B
Marketcap
0,43ย โ‚ฌ
Share price
-4.78%
Change (1 day)
-71.57%
Change (1 year)

P/S ratio for Akebia Therapeutics (AKBA)

P/S ratio as of November 2026 (TTM): 0.6677

According to Akebia Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.26. At the end of 2026 the company had a P/S ratio of 1.22.

P/S ratio history for Akebia Therapeutics from 2014 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20261.22-30.2%
20251.74-34.44%
20242.66121.29%
20231.20230.14%
20220.3636-80.36%
20211.8535.09%
20201.37-40.3%
20192.30-26.23%
20183.11-21.21%
20173.95-98.48%
2016260
2015N/A
2014N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.92 937.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.28 691.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
6.47 869.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
23.4 3,398.54%๐Ÿ‡บ๐Ÿ‡ธ USA